Preliminary data suggests mixing Covid-19 vaccine increases reactogenicity
Researchers running the University of Oxford-led Com-COV study – launched earlier this year to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine – report preliminary data revealing more frequent mild to moderate reactions in mixed schedules compared to standard schedules. Research, from Com-COV study comparing mixed dosing schedules of Pfizer / Oxford-AstraZeneca […]